BMS Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$658K Sell
8,136
-2,852
-26% -$233K 0.43% 35
2023
Q1
$874K Buy
10,988
+212
+2% +$15K 0.6% 28
2022
Q4
$729K Buy
10,776
+298
+3% +$17.5K 0.48% 35
2022
Q3
$522K Buy
10,478
+12
+0.1% +$643 0.37% 55
2022
Q2
$583K Buy
+10,466
New +$581K 0.38% 44

Other funds holding NVO

BMS Financial Advisors's NVO Position: Q2 2023 in Review

BMS Financial Advisors reduced its Novo Nordisk (NVO) stake by 26% in Q2 2023, selling an estimated $233K and leaving 8,136 shares worth $658K. The position accounts for 0.43% of the portfolio, ranked #35.

BMS Financial Advisors first reported a position in NVO in Q2 2022 and has held it in 5 quarters since. The position peaked at $874K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • BMS Financial Advisors held 8,136 shares of Novo Nordisk worth $658K as of Q2 2023.
  • BMS Financial Advisors sold 2,852 Novo Nordisk shares in Q2 2023, an estimated $233K.
  • Novo Nordisk made up 0.43% of BMS Financial Advisors's portfolio in Q2 2023, its #35 holding.
  • BMS Financial Advisors first reported a position in Novo Nordisk in Q2 2022 and has held it in 5 quarters since.
  • BMS Financial Advisors's Novo Nordisk position peaked at $874K in Q1 2023.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on BMS Financial Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.